Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
In 2019, the market size of Biologic Therapeutics Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologic Therapeutics Drugs.
This report studies the global market size of Biologic Therapeutics Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biologic Therapeutics Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Market Segment by Product Type
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Market Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biologic Therapeutics Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biologic Therapeutics Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biologic Therapeutics Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Biologic Therapeutics Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologic Therapeutics Drugs.
This report studies the global market size of Biologic Therapeutics Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biologic Therapeutics Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Market Segment by Product Type
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Market Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biologic Therapeutics Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biologic Therapeutics Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biologic Therapeutics Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Humans
1.3.3 Avian Cell Culture
1.3.4 Yeast
1.3.5 Bacteria
1.3.6 Insects Cell Culture
1.3.7 Transgenics
1.4 Market Segment by Application
1.4.1 Global Biologic Therapeutics Drugs Market Share by Application (2019-2025)
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Drugs Market Size
2.1.1 Global Biologic Therapeutics Drugs Revenue 2014-2025
2.1.2 Global Biologic Therapeutics Drugs Sales 2014-2025
2.2 Biologic Therapeutics Drugs Growth Rate by Regions
2.2.1 Global Biologic Therapeutics Drugs Sales by Regions 2014-2019
2.2.2 Global Biologic Therapeutics Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biologic Therapeutics Drugs Sales by Manufacturers
3.1.1 Biologic Therapeutics Drugs Sales by Manufacturers 2014-2019
3.1.2 Biologic Therapeutics Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Biologic Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Biologic Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Biologic Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Biologic Therapeutics Drugs Price by Manufacturers
3.4 Key Manufacturers Biologic Therapeutics Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biologic Therapeutics Drugs Market
3.6 Key Manufacturers Biologic Therapeutics Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Humans Sales and Revenue (2014-2019)
4.1.2 Avian Cell Culture Sales and Revenue (2014-2019)
4.1.3 Yeast Sales and Revenue (2014-2019)
4.1.4 Bacteria Sales and Revenue (2014-2019)
4.1.5 Insects Cell Culture Sales and Revenue (2014-2019)
4.1.6 Transgenics Sales and Revenue (2014-2019)
4.2 Global Biologic Therapeutics Drugs Sales Market Share by Type
4.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type
4.4 Biologic Therapeutics Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biologic Therapeutics Drugs Sales by Application
6 United States
6.1 United States Biologic Therapeutics Drugs Breakdown Data by Company
6.2 United States Biologic Therapeutics Drugs Breakdown Data by Type
6.3 United States Biologic Therapeutics Drugs Breakdown Data by Application
7 European Union
7.1 European Union Biologic Therapeutics Drugs Breakdown Data by Company
7.2 European Union Biologic Therapeutics Drugs Breakdown Data by Type
7.3 European Union Biologic Therapeutics Drugs Breakdown Data by Application
8 China
8.1 China Biologic Therapeutics Drugs Breakdown Data by Company
8.2 China Biologic Therapeutics Drugs Breakdown Data by Type
8.3 China Biologic Therapeutics Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biologic Therapeutics Drugs Breakdown Data by Company
9.2 Rest of World Biologic Therapeutics Drugs Breakdown Data by Type
9.3 Rest of World Biologic Therapeutics Drugs Breakdown Data by Application
9.4 Rest of World Biologic Therapeutics Drugs Breakdown Data by Countries
9.4.1 Rest of World Biologic Therapeutics Drugs Sales by Countries
9.4.2 Rest of World Biologic Therapeutics Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.1.4 Biologic Therapeutics Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.2.4 Biologic Therapeutics Drugs Product Introduction
10.2.5 AstraZeneca Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.3.4 Biologic Therapeutics Drugs Product Introduction
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.4.4 Biologic Therapeutics Drugs Product Introduction
10.4.5 Merck Recent Development
10.5 Smith Medical
10.5.1 Smith Medical Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.5.4 Biologic Therapeutics Drugs Product Introduction
10.5.5 Smith Medical Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.6.4 Biologic Therapeutics Drugs Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Concord Biotech
10.7.1 Concord Biotech Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.7.4 Biologic Therapeutics Drugs Product Introduction
10.7.5 Concord Biotech Recent Development
10.8 Aurobindo Pharma
10.8.1 Aurobindo Pharma Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.8.4 Biologic Therapeutics Drugs Product Introduction
10.8.5 Aurobindo Pharma Recent Development
10.9 H. Lundbeck
10.9.1 H. Lundbeck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.9.4 Biologic Therapeutics Drugs Product Introduction
10.9.5 H. Lundbeck Recent Development
10.10 Retractable Technologies
10.10.1 Retractable Technologies Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.10.4 Biologic Therapeutics Drugs Product Introduction
10.10.5 Retractable Technologies Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biologic Therapeutics Drugs Sales Channels
11.2.2 Biologic Therapeutics Drugs Distributors
11.3 Biologic Therapeutics Drugs Customers
12 Market Forecast
12.1 Global Biologic Therapeutics Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Biologic Therapeutics Drugs Sales Forecast by Type
12.3 Global Biologic Therapeutics Drugs Sales Forecast by Application
12.4 Biologic Therapeutics Drugs Forecast by Regions
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Biologic Therapeutics Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Humans
1.3.3 Avian Cell Culture
1.3.4 Yeast
1.3.5 Bacteria
1.3.6 Insects Cell Culture
1.3.7 Transgenics
1.4 Market Segment by Application
1.4.1 Global Biologic Therapeutics Drugs Market Share by Application (2019-2025)
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Drugs Market Size
2.1.1 Global Biologic Therapeutics Drugs Revenue 2014-2025
2.1.2 Global Biologic Therapeutics Drugs Sales 2014-2025
2.2 Biologic Therapeutics Drugs Growth Rate by Regions
2.2.1 Global Biologic Therapeutics Drugs Sales by Regions 2014-2019
2.2.2 Global Biologic Therapeutics Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biologic Therapeutics Drugs Sales by Manufacturers
3.1.1 Biologic Therapeutics Drugs Sales by Manufacturers 2014-2019
3.1.2 Biologic Therapeutics Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Biologic Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Biologic Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Biologic Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Biologic Therapeutics Drugs Price by Manufacturers
3.4 Key Manufacturers Biologic Therapeutics Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biologic Therapeutics Drugs Market
3.6 Key Manufacturers Biologic Therapeutics Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Humans Sales and Revenue (2014-2019)
4.1.2 Avian Cell Culture Sales and Revenue (2014-2019)
4.1.3 Yeast Sales and Revenue (2014-2019)
4.1.4 Bacteria Sales and Revenue (2014-2019)
4.1.5 Insects Cell Culture Sales and Revenue (2014-2019)
4.1.6 Transgenics Sales and Revenue (2014-2019)
4.2 Global Biologic Therapeutics Drugs Sales Market Share by Type
4.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type
4.4 Biologic Therapeutics Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biologic Therapeutics Drugs Sales by Application
6 United States
6.1 United States Biologic Therapeutics Drugs Breakdown Data by Company
6.2 United States Biologic Therapeutics Drugs Breakdown Data by Type
6.3 United States Biologic Therapeutics Drugs Breakdown Data by Application
7 European Union
7.1 European Union Biologic Therapeutics Drugs Breakdown Data by Company
7.2 European Union Biologic Therapeutics Drugs Breakdown Data by Type
7.3 European Union Biologic Therapeutics Drugs Breakdown Data by Application
8 China
8.1 China Biologic Therapeutics Drugs Breakdown Data by Company
8.2 China Biologic Therapeutics Drugs Breakdown Data by Type
8.3 China Biologic Therapeutics Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biologic Therapeutics Drugs Breakdown Data by Company
9.2 Rest of World Biologic Therapeutics Drugs Breakdown Data by Type
9.3 Rest of World Biologic Therapeutics Drugs Breakdown Data by Application
9.4 Rest of World Biologic Therapeutics Drugs Breakdown Data by Countries
9.4.1 Rest of World Biologic Therapeutics Drugs Sales by Countries
9.4.2 Rest of World Biologic Therapeutics Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.1.4 Biologic Therapeutics Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.2.4 Biologic Therapeutics Drugs Product Introduction
10.2.5 AstraZeneca Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.3.4 Biologic Therapeutics Drugs Product Introduction
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.4.4 Biologic Therapeutics Drugs Product Introduction
10.4.5 Merck Recent Development
10.5 Smith Medical
10.5.1 Smith Medical Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.5.4 Biologic Therapeutics Drugs Product Introduction
10.5.5 Smith Medical Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.6.4 Biologic Therapeutics Drugs Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Concord Biotech
10.7.1 Concord Biotech Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.7.4 Biologic Therapeutics Drugs Product Introduction
10.7.5 Concord Biotech Recent Development
10.8 Aurobindo Pharma
10.8.1 Aurobindo Pharma Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.8.4 Biologic Therapeutics Drugs Product Introduction
10.8.5 Aurobindo Pharma Recent Development
10.9 H. Lundbeck
10.9.1 H. Lundbeck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.9.4 Biologic Therapeutics Drugs Product Introduction
10.9.5 H. Lundbeck Recent Development
10.10 Retractable Technologies
10.10.1 Retractable Technologies Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Biologic Therapeutics Drugs
10.10.4 Biologic Therapeutics Drugs Product Introduction
10.10.5 Retractable Technologies Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biologic Therapeutics Drugs Sales Channels
11.2.2 Biologic Therapeutics Drugs Distributors
11.3 Biologic Therapeutics Drugs Customers
12 Market Forecast
12.1 Global Biologic Therapeutics Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Biologic Therapeutics Drugs Sales Forecast by Type
12.3 Global Biologic Therapeutics Drugs Sales Forecast by Application
12.4 Biologic Therapeutics Drugs Forecast by Regions
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Biologic Therapeutics Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
